Department of Dermatology

FV03 MEK Inhibitors improved the Survival of NRAS-mutated Melanoma Patients by using Checkpoint Inhibitors: Results of a retrospective, multicenter Analysis of 364 Patients (2018) Kirchberger MC, Ugurel S, Mangana J, Heppt M, Eigentler T, Berking C, Schadendorf D, et al. Conference contribution Fear of cancer progression in patients with stage IA malignant melanoma (2018) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Journal article Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry (2018) Worm M, Francuzik W, Renaudin JM, Bilo MB, Cardona V, Hofmeier KS, Kohli A, et al. Journal article From relative to absolute treatment outcomes-Correlation of PASI 90 and PASI <= 2 in three clinical trials with secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution Editorial: Foundations of Theoretical Approaches in Systems Biology (2018) Marin-Sanguino A, Vera J, Alves R Journal article, Editorial Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors (2018) Sirtl S, Knoll G, Dieu Thuy Trinh , Lang I, Siegmund D, Gross S, Schuler-Thurner B, et al. Journal article From relative to absolute Treatment Goals - Correlation of PASI 90 and PASI <=2 in three clinical Studies with Secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution Can checkpoint inhibitor therapy improve response to chemotherapy? (2018) Kirchberger MC, Schilling B, Haferkamp S, Boßerhoff AK, Schuler G, Heinzerling L Journal article Type IV contact allergies in the food processing industry: an update (2018) Bauer A, Schubert S, Geier J, Mahler V Journal article Systemische Therapien des Ulcus cruris (2018) Dissemond J, Goerge T, Kroeger K, Funke-Lorenz C, Reich-Schupke S, Erfurt-Berge C Journal article